Global Beta Agonist Feed Additive 麻豆原创 Growth 2024-2030

Publication ID:

LPI05243982

Publication Date:

May 23, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

Beta Agonist Feed Additive is a type of synthetic compound that mimics some of the effects of naturally-occurring substances by binding to beta-receptors on the surface of cells within the muscle, fat, and other tissues of animals. Beta Agonist Feed Additive is used to enhance lean muscle gain, increase growth rate, and improve feed efficiency in livestock, especially before slaughtering. There are two main types of Beta Agonist Feed Additive: ractopamine and zilpaterol, which are approved by the FDA for use in swine, turkeys, and cattle.
The global Beta Agonist Feed Additive market size is projected to grow from US$ 217.2 million in 2023 to US$ 392.4 million in 2030; it is expected to grow at a CAGR of 8.8% from 2024 to 2030.
The 鈥淏eta Agonist Feed Additive Industry Forecast鈥� looks at past sales and reviews total world Beta Agonist Feed Additive sales in 2023, providing a comprehensive analysis by region and market sector of projected Beta Agonist Feed Additive sales for 2024 through 2030. With Beta Agonist Feed Additive sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta Agonist Feed Additive industry.
This Insight Report provides a comprehensive analysis of the global Beta Agonist Feed Additive landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta Agonist Feed Additive portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Beta Agonist Feed Additive market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta Agonist Feed Additive and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta Agonist Feed Additive.
According to our Fee Research Center, in 2022, global total production of feed was about 1.2 billion tons. Key producing regions are Asia, Europe and North America, top ten countries hold about 65% of global feed production. China, United States, Brazil and India, as the top four countries, accounted for half of the total feed production.
This report presents a comprehensive overview, market shares, and growth opportunities of Beta Agonist Feed Additive market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Ractopamine
Zilpaterol
Segmentation by application
Swine
Ruminants
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck Animal Health
Elanco Animal Health
Zoetis
Quality Liquid Feeds
Heer Pharma Private Limited
Key Questions Addressed in this Report
What is the 10-year outlook for the global Beta Agonist Feed Additive market?
What factors are driving Beta Agonist Feed Additive market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Beta Agonist Feed Additive market opportunities vary by end market size?
How does Beta Agonist Feed Additive break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Beta Agonist Feed Additive Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Beta Agonist Feed Additive by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Beta Agonist Feed Additive by Country/Region, 2019, 2023 & 2030
2.2 Beta Agonist Feed Additive Segment by Type
2.2.1 Ractopamine
2.2.2 Zilpaterol
2.3 Beta Agonist Feed Additive Sales by Type
2.3.1 Global Beta Agonist Feed Additive Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Beta Agonist Feed Additive Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Beta Agonist Feed Additive Sale Price by Type (2019-2024)
2.4 Beta Agonist Feed Additive Segment by Application
2.4.1 Swine
2.4.2 Ruminants
2.4.3 Others
2.5 Beta Agonist Feed Additive Sales by Application
2.5.1 Global Beta Agonist Feed Additive Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Beta Agonist Feed Additive Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Beta Agonist Feed Additive Sale Price by Application (2019-2024)
3 Global Beta Agonist Feed Additive by Company
3.1 Global Beta Agonist Feed Additive Breakdown Data by Company
3.1.1 Global Beta Agonist Feed Additive Annual Sales by Company (2019-2024)
3.1.2 Global Beta Agonist Feed Additive Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Beta Agonist Feed Additive Annual Revenue by Company (2019-2024)
3.2.1 Global Beta Agonist Feed Additive Revenue by Company (2019-2024)
3.2.2 Global Beta Agonist Feed Additive Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Beta Agonist Feed Additive Sale Price by Company
3.4 Key Manufacturers Beta Agonist Feed Additive Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Beta Agonist Feed Additive Product Location Distribution
3.4.2 Players Beta Agonist Feed Additive Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Beta Agonist Feed Additive by Geographic Region
4.1 World Historic Beta Agonist Feed Additive 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Beta Agonist Feed Additive Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Beta Agonist Feed Additive Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Beta Agonist Feed Additive 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Beta Agonist Feed Additive Annual Sales by Country/Region (2019-2024)
4.2.2 Global Beta Agonist Feed Additive Annual Revenue by Country/Region (2019-2024)
4.3 Americas Beta Agonist Feed Additive Sales Growth
4.4 APAC Beta Agonist Feed Additive Sales Growth
4.5 Europe Beta Agonist Feed Additive Sales Growth
4.6 Middle East & Africa Beta Agonist Feed Additive Sales Growth
5 Americas
5.1 Americas Beta Agonist Feed Additive Sales by Country
5.1.1 Americas Beta Agonist Feed Additive Sales by Country (2019-2024)
5.1.2 Americas Beta Agonist Feed Additive Revenue by Country (2019-2024)
5.2 Americas Beta Agonist Feed Additive Sales by Type
5.3 Americas Beta Agonist Feed Additive Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beta Agonist Feed Additive Sales by Region
6.1.1 APAC Beta Agonist Feed Additive Sales by Region (2019-2024)
6.1.2 APAC Beta Agonist Feed Additive Revenue by Region (2019-2024)
6.2 APAC Beta Agonist Feed Additive Sales by Type
6.3 APAC Beta Agonist Feed Additive Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Beta Agonist Feed Additive by Country
7.1.1 Europe Beta Agonist Feed Additive Sales by Country (2019-2024)
7.1.2 Europe Beta Agonist Feed Additive Revenue by Country (2019-2024)
7.2 Europe Beta Agonist Feed Additive Sales by Type
7.3 Europe Beta Agonist Feed Additive Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Beta Agonist Feed Additive by Country
8.1.1 Middle East & Africa Beta Agonist Feed Additive Sales by Country (2019-2024)
8.1.2 Middle East & Africa Beta Agonist Feed Additive Revenue by Country (2019-2024)
8.2 Middle East & Africa Beta Agonist Feed Additive Sales by Type
8.3 Middle East & Africa Beta Agonist Feed Additive Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beta Agonist Feed Additive
10.3 Manufacturing Process Analysis of Beta Agonist Feed Additive
10.4 Industry Chain Structure of Beta Agonist Feed Additive
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Beta Agonist Feed Additive Distributors
11.3 Beta Agonist Feed Additive Customer
12 World Forecast Review for Beta Agonist Feed Additive by Geographic Region
12.1 Global Beta Agonist Feed Additive 麻豆原创 Size Forecast by Region
12.1.1 Global Beta Agonist Feed Additive Forecast by Region (2025-2030)
12.1.2 Global Beta Agonist Feed Additive Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Beta Agonist Feed Additive Forecast by Type
12.7 Global Beta Agonist Feed Additive Forecast by Application
13 Key Players Analysis
13.1 Merck Animal Health
13.1.1 Merck Animal Health Company Information
13.1.2 Merck Animal Health Beta Agonist Feed Additive Product Portfolios and Specifications
13.1.3 Merck Animal Health Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Animal Health Main Business Overview
13.1.5 Merck Animal Health Latest Developments
13.2 Elanco Animal Health
13.2.1 Elanco Animal Health Company Information
13.2.2 Elanco Animal Health Beta Agonist Feed Additive Product Portfolios and Specifications
13.2.3 Elanco Animal Health Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Elanco Animal Health Main Business Overview
13.2.5 Elanco Animal Health Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Beta Agonist Feed Additive Product Portfolios and Specifications
13.3.3 Zoetis Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Quality Liquid Feeds
13.4.1 Quality Liquid Feeds Company Information
13.4.2 Quality Liquid Feeds Beta Agonist Feed Additive Product Portfolios and Specifications
13.4.3 Quality Liquid Feeds Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Quality Liquid Feeds Main Business Overview
13.4.5 Quality Liquid Feeds Latest Developments
13.5 Heer Pharma Private Limited
13.5.1 Heer Pharma Private Limited Company Information
13.5.2 Heer Pharma Private Limited Beta Agonist Feed Additive Product Portfolios and Specifications
13.5.3 Heer Pharma Private Limited Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Heer Pharma Private Limited Main Business Overview
13.5.5 Heer Pharma Private Limited Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.